December 7, 2020
Since the Weston Family Foundation launched the Weston Brain Institute in 2014, more than $85 million has been awarded to researchers at numerous advanced research institutions across the country. Our grants have funded critical translational research that advances our understanding and treatment of neurodegenerative diseases of aging in Canada.
Today, I have some important news to share regarding several of the Weston Brain Institute’s funding programs.
As of January 2021, we will be suspending our Rapid Response, Transformational Research, Early Phase Clinical Trials and Big Ideas program calls. This pause will provide us with an opportunity to reflect on our current programmatic designs, our achievements to date, and new mechanisms of support we may wish to explore in the future.
For clarity, all grants that are being adjudicated through our current program competitions will be awarded as scheduled:
The Weston Brain Institute’s goal remains to reduce the burden of neurodegenerative diseases of aging and to improve the overall well-being of Canadians. This goal aligns with the strategic direction of the Weston Family Foundation, which provides all funding to WBI.
If you have any questions regarding WBI’s funding programs, please contact Dr. Cristina Tang at Cristina.Tang@westonbrain.org. For additional information about WBI, please visit westonbrain.org. For more information about the Weston Family Foundation, please visit westonfoundation.ca.
Thank you to all of our grantees for the research you undertake to advance our understanding of neurodegenerative diseases of aging. We value your work and look forward to ongoing and future collaboration.
Dr. Lara O’Donnell
Lara O’Donnell, PhD